Serum C-reactive protein is being investigated as a biomarker to predict adalimumab response in hidradenitis suppurativa patients. Elevated baseline C-reactive protein levels correlate with a reduced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback